Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethics in liver transplantation.

Sanjay Kulkarni1, David C Cronin

  • 1Section of Organ Transplantation and Immunology, Yale University School of Medicine, New Haven, Connecticut 06520-8062, USA.

Seminars in Liver Disease
|July 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation.

Journal of the American Society of Nephrology : JASN·2026
Same author

Patient-reported outcomes after single-stage spiral preputial graft urethroplasty for panurethral strictures: a single-centre prospective study.

BMC urology·2026
Same author

Clinical outcomes of bovine pericardial tissue patch grafting for surgical correction of Peyronie's disease: a prospective single-center case series.

Basic and clinical andrology·2026
Same author

AOOS Reflects an Opportunity for Better, Inclusive, Policy-Making.

The American journal of bioethics : AJOB·2026
Same author

Transferrin conjugated pH/NIR-responsive black phosphorus nanoplatform: A novel multimodal approach for breast cancer theranostics.

International journal of pharmaceutics: X·2025
Same author

Engineered transferrin-conjugated PEGylated multifunctional MOF-74 as precision nanotheranostics for triple-negative breast cancer.

International journal of biological macromolecules·2025

The current liver allocation system, based on the Model for End-Stage Liver Disease (MELD) score, is not equally distributing livers. This leads to disparities in transplant access for critically ill patients nationwide.

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Public Health Policy

Background:

  • Liver transplantation is a vital treatment for end-stage liver disease, with survival rates significantly improved by advancements in immunosuppression, comorbidity management, and surgical techniques.
  • A critical limitation to liver transplantation is the insufficient supply of donor livers, necessitating an equitable organ allocation system.
  • The Model for End-Stage Liver Disease (MELD) score was implemented to prioritize patients with the most severe liver disease for transplantation, aiming to reduce mortality on waiting lists.

Purpose of the Study:

  • To evaluate the effectiveness and equity of the current deceased-donor liver allocation system based on MELD scores.
  • To identify deficiencies in the MELD-based allocation system concerning geographical and regional disparities.
  • To assess whether the national directive of transplanting the sickest patients first is being achieved across all regions.

Related Experiment Videos

Main Methods:

  • Analysis of deceased-donor liver allocation data across different geographical regions.
  • Comparison of MELD scores among patients awaiting liver transplantation in various regions.
  • Evaluation of the distribution patterns of available donor livers in relation to patient MELD scores.

Main Results:

  • Significant inequalities in the distribution of deceased-donor livers have been observed across and within different regions.
  • The MELD score, while intended to prioritize the sickest patients, does not guarantee equitable access to liver transplantation nationwide.
  • Disparities in liver allocation persist, indicating that the current system does not fully realize the goal of transplanting the sickest patients first regardless of their location.

Conclusions:

  • The current MELD-based liver allocation system exhibits significant regional disparities, hindering equitable access to transplantation.
  • Further refinement of the liver allocation policy is necessary to address geographical inequalities and ensure the sickest patients receive timely transplants.
  • Addressing these deficiencies is crucial for optimizing the use of limited donor livers and improving outcomes for all patients with end-stage liver disease awaiting transplantation.